Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05960461 · ClinicalTrials.gov registry record · NA

Families Moving Forward (FMF) Connect Pro for Mental Health Providers

A NA study of Fetal Alcohol Spectrum Disorders, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT05960461: Recruiting NA study of Fetal Alcohol Spectrum Disorders, sponsored by University of Rochester.

NCT05960461 is a NA study of Fetal Alcohol Spectrum Disorders that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 250 participants, above the 81-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (209% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05960461, a NA study of Fetal Alcohol Spectrum Disorders, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test a new provider-assisted version of the caregiver Families Moving Forward (FMF) Connect app ("FMF Connect Pro") with mental health providers in the United States. In FMF Connect Pro, mental health providers learn to do routine screening for prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support families in using the FMF Connect caregiver app. Two different training methods will be compared with a waitlist group in this study. The first training method involves 13-sessions of tele-mentoring using an Extension of Community Healthcare Outcomes (ECHO) approach. The second training method involves a self-directed approach in which providers will access similar content in any asynchronous format on a website. The main questions this study aims to answer are: * What is the proportion of agencies and providers who accept and participate in the clinical trial (Reach)? * Do study groups differ on provider outcome measures of Effectiveness (clients screened/diagnosed), Adoption (provider change in knowledge, self-efficacy), Implementation (practice change, FMF Connect Pro Dashboard usage), and Maintenance of FASD-informed care practice change? All mental health providers in the study will complete online assessments at study entry, 6 months, and 12 months.

Primary Outcome

Research staff will document the number of mental health agencies who agree to participate in the introductory webinar presentation out of the total number approached.

Interventions

  • BEHAVIORAL FMF (Families Moving Forward) Connect Pro
  • BEHAVIORAL ECHO (Extension of Community Healthcare Outcomes) implementation.
  • BEHAVIORAL Self-Directed Learning implementation.

Study Locations (1)

New York

  • Mt. Hope Family Center - Rochester

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-03-22
Est. Completion 2027-04-30
Phase NA
University of Rochester

636 total trials

What NCT05960461 shows while recruiting

NCT05960461 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 81-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (209% higher).

The record links to 1 condition, with Fetal Alcohol Spectrum Disorders appearing as the primary indexed condition, and to 3 interventions - of which FMF (Families Moving Forward) Connect Pro is the first listed.

NCT05960461 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05960461 about?

NCT05960461 is a clinical study titled "Families Moving Forward (FMF) Connect Pro for Mental Health Providers". The goal of this clinical trial is to test a new provider-assisted version of the caregiver Families Moving Forward (FMF) Connect app ("FMF Connect Pro") with mental health providers in the United States. In FMF Connect Pro, mental health providers learn to do routine screening for prenatal alcohol ...

What is the current status of trial NCT05960461?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-03-22. Estimated completion is 2027-04-30.

What conditions does trial NCT05960461 study?

This clinical trial studies the following conditions: Fetal Alcohol Spectrum Disorders.

What interventions are being tested in trial NCT05960461?

The interventions under investigation include: FMF (Families Moving Forward) Connect Pro (BEHAVIORAL), ECHO (Extension of Community Healthcare Outcomes) implementation. (BEHAVIORAL), Self-Directed Learning implementation. (BEHAVIORAL).

Who is sponsoring clinical trial NCT05960461?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05960461 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fetal Alcohol Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05960461's enrollment target sits among peer trials

250 1st of 10 higher than 10 of 10 other Fetal Alcohol Spectrum Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fetal Alcohol Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05960461, the US trial registry maintained by the National Library of Medicine. NCT05960461 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.